作者：
VanderPloeg,A.T. [1]
;
Barohn,R. [2]
;
Carlson,L. [3]
;
Charrow,J. [4]
;
Clemens,P.R. [5]
;
Hopkin,R.J. [6]
;
Kishnani,P.S. [7]
;
Laforêt,P. [8]
;
Morgan,C. [9]
;
Nations,S. [10]
;
Pestronk,A. [11]
;
Plotkin,H. [12]
;
Rosenbloom,B.E. ;
Sims,K.B. ;
Tsao,E.
作者单位：
Genzyme Corporation, Boston, MA, United States
[1]
Division Chief Medical Genetics, Duke University Medical Center, Durham, NC, United States
[2]
Department of Neurology, Kansas University, Kansas City, MO, United States
[3]
Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, Paris, France
[4]
Washington University, School of Medicine, St. Louis, MO, United States
[5]
Division of Genetics Birth Defects and Metabolism, Children's Memorial Hospital, Chicago, IL
[6]
Department of Pediatrics, Division of Metabolic Diseases and Genetics, Center for Lysosomal and
[7]
Tower Hematology Oncology, Beverly Hills, CA, United States
[8]
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
[9]
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
[10]
Neurology Service, Department of Veterans Affairs Medical Center, and Department of Neurology
[11]
Southwestern Medical Center of Dallas, University of Texas, Dallas, TX, United States
[12]
发布时间
2013-11-20
换一批
